Reports
Sale
Global Prostate Health Market Size, Share, Trends, Growth: By Treatment Type: Hormonal Therapy, Chemotherapy, Surgical Treatments, Others; By Indications: Benign Prostatic Hyperplasia (BPH), Prostatitis, Prostate Cancer, Others; By Age Group: Adults, Geriatrics, Others; By End User; Regional Analysis; Competitive Landscape; 2024-2032
Global Prostate Health Market Outlook
The global prostate health market size was valued at USD 38.1 billion in 2023, driven by the increasing incidence of prostate cancer across the globe. The market size is anticipated to grow at a CAGR of 9.1% during the forecast period of 2024-2032 to achieve a value of USD 83.4 billion by 2032.
Prostate Health: Introduction
The prostate is a small, rubbery gland in the male reproductive system. It is located in the pelvis, below the bladder and in front of the rectum. It is about the size of a walnut and weighs about 11 grams. The prostate's primary function is to produce the fluid that nourishes and transports sperm. This fluid, called seminal fluid, mixes with sperm from the testes to make semen. Prostate's muscles also help push semen through the urethra.
Prostate health refers to the well-being and proper functioning of the prostate gland, which is a small, walnut-sized organ located just below the bladder in men. The prostate gland plays a crucial role in the male reproductive system by producing seminal fluid, which nourishes and transports sperm during ejaculation.
Global Prostate Health Market Analysis
The growth of the global market for prostate health is driven by the increasing numbers of FDA approvals for new drugs targeted at addressing various aspects of prostate health. For example, approval of the fixed-dose combination of niraparib and abiraterone acetate for patients with certain types of prostate cancer, offering new treatment options is a major step and hope for new and effective treatment for prostate cancers. The market is also driven by the heavy investments by the leading key players. Increasing investments and funding in prostate health research and treatment innovations are also market trends influencing the global prostate health market growth. Researchers have been exploring novel therapies that show promising results in treating prostate cancer, even in cases where existing treatments have proven ineffective. These innovations bring hope to those patients who are suffering from the disease and offer potential innovation in prostate cancer management. Increasing efforts to reduce harm from prostate cancer screening are also accountable for the market growth.
Additionally, strategic mergers and acquisitions among key players in the healthcare industry are also contributing to the market growth. Collaborative efforts, such as the merger between Pfizer Inc. and Seagen Inc., demonstrate a concerted effort to combat cancer and develop transformative therapies. These partnerships are expected to further propel the prostate health market growth.
Global Prostate Health Market Segmentations
Market by Treatment Type
- Hormonal Therapy
- Chemotherapy
- Surgical Treatments
- Radical Prostatectomy
- Orchidectomy
- Trans Urethral Resection
- Others
- Other Treatment Types
Market Breakup by Indications
- Benign Prostatic Hyperplasia (BPH)
- Prostatitis
- Prostate Cancer
- Others
Market Breakup by Age Group
- Adults
- Geriatrics
- Others
Market Breakup by End User
- Hospitals and Clinics
- Speciality Clinics
- Homecare Settings
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Prostate Health Market Overview
The growth of global prostate health market growth is driven by several key factors including prostate cancer being the second most common cancer in men worldwide, highlighting the quick need for effective treatments and diagnostics. The growing prevalence of benign prostatic hyperplasia (BPH), a common condition among aging men, further contributes to the market's expansion. The increasing geriatric population acts as a major factor driving the market growth as well. The emergence of new treatment therapies and techniques for prostate cancer holds promise in improving patient outcomes and potential to drive market growth. Rapid growth in the availability of biomarker testing, allowing for early detection and more precise treatment decisions also collectively accountable for the market growth. Investments in research and development, coupled with a surge in upcoming pipeline medicines and the availability of innovative prostate treatments, are propelling the global prostate health market growth.
Geographically, North America is leading the regional market for prostate health, and it is expected to lead the market for the forecast period as well. The prevalence of prostate diseases, including prostate cancer in the region is also increasing, which is driving the market growth. The increased investment in research and development, the promising pipeline of medicines, and the availability of novel prostate health solutions collectively contribute to the market growth.
Global Prostate Health Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott
- Novartis AG
- Teleflex
- AstraZeneca PLC
- Bayer AG
- Sanofi
- Pfizer
- Clovis Oncology
- Siemens Healthcare GmbH
- Elekta
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by Indications |
|
| Breakup by Age Group |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Prostate Health Market Overview
3.1 Global Prostate Health Market Historical Value (2017-2023)
3.2 Global Prostate Health Market Forecast Value (2024-2032)
4 Global Prostate Health Market Landscape
4.1 Global Prostate Health Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Prostate Health Product Landscape
4.2.1 Analysis by Treatment
4.2.2 Analysis by Indications
4.2.3 Analysis by Age Group
5 Global Prostate Health Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Prostate Health Market Segmentation
6.1 Global Prostate Health Market by Treatment Type
6.1.1 Market Overview
6.1.2 Hormonal Therapy
6.1.3 Chemotherapy
6.1.4 Surgical Treatments
6.1.4.1 Radical Prostatectomy
6.1.4.2 Orchidectomy
6.1.4.3 Trans Urethral Resection
6.1.4.4 Others
6.1.5 Other Treatment Types
6.2 Global Prostate Health Market by Indications
6.2.1 Market Overview
6.2.2 Benign Prostatic Hyperplasia (BPH)
6.2.3 Prostatitis
6.2.4 Prostate Cancer
6.2.5 Others
6.3 Global Prostate Health Market by Age Group
6.3.1 Market Overview
6.3.2 Adults
6.3.3 Geriatrics
6.3.4 Others
6.4 Global Prostate Health Market by End User
6.4.1 Market Overview
6.4.2 Hospitals and Clinics
6.4.3 Speciality Clinics
6.4.4 Homecare Settings
6.4.5 Others
6.5 Global Prostate Health Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Prostate Health Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Prostate Health Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Prostate Health Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Prostate Health Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Prostate Health Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Novartis AG
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Teleflex
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 AstraZeneca PLC
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Bayer AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Sanofi
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Pfizer
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Clovis Oncology
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Siemens Healthcare GmbH
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Elekta
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
18 Global Prostate Health Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The global prostate health market value reached close to USD 38.1 billion in 2023, driven by the increased awareness about the importance of prostate health.
The market is anticipated to grow at a CAGR of 9.1% during the forecast period of 2024-2032 and is likely to reach a market value of USD 83.4 billion by 2032.
The increasing geriatric population and increasing prevalence of benign prostatic hyperplasia are major factors driving the market growth.
The increasing number of FDA approvals and research and development activities for the development of new drugs and treatments are among the major trends influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Various products in the market include hormonal therapy, chemotherapy, and surgical treatments, among others.
The indication is benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer, among others.
The age group includes adults and pediatrics, among others.
End users in the market are hospitals and clinics, specialty clinics, and home care settings, among others.
Key players involved in the market are Abbott, Novartis AG, Teleflex, AstraZeneca PLC, Bayer AG, Sanofi, Pfizer, Clovis Oncology, Siemens Healthcare GmbH, and Elekta.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER